Abstract | BACKGROUND: PATIENTS AND METHODS: RESULTS: The median number of courses for vinblastine was 3.5 (range, 1-6). Three patients had partial responses in soft tissue metastases (21%). Four patients had stable disease. Four patients had > grade 2 neutropenia, and 1 patient had grade 4 thrombocytopenia. There were 2 cases of grade 3 constipation, 2 of grade 3 nausea, and 1 each of grade 2 neuropathy and myalgia. There was no treatment-related mortality. CONCLUSIONS:
|
Authors | S D Huan, J C Yau, E Tomiak, R Goel, C Cripps, S Z Gertler, I A Prosser, D J Stewart |
Journal | Tumori
(Tumori)
1996 Nov-Dec
Vol. 82
Issue 6
Pg. 576-8
ISSN: 0300-8916 [Print] United States |
PMID | 9061067
(Publication Type: Journal Article)
|
Chemical References |
- Antibiotics, Antineoplastic
- Antineoplastic Agents, Phytogenic
- Vinblastine
- Hydroxyurea
|
Topics |
- Adult
- Aged
- Antibiotics, Antineoplastic
(administration & dosage)
- Antineoplastic Agents, Phytogenic
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Breast Neoplasms
(drug therapy, pathology)
- Drug Resistance, Neoplasm
- Female
- Humans
- Hydroxyurea
(administration & dosage)
- Middle Aged
- Treatment Outcome
- Vinblastine
(administration & dosage)
|